Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Short term Debt (2021 - 2024)

Biodesix's Short term Debt history spans 4 years, with the latest figure at $5.8 million for Q2 2024.

  • For Q2 2024, Short term Debt fell 59.91% year-over-year to $5.8 million; the TTM value through Jun 2024 reached $5.8 million, down 59.91%, while the annual FY2023 figure was $21.9 million, 111.36% up from the prior year.
  • Short term Debt reached $5.8 million in Q2 2024 per BDSX's latest filing, down from $19.2 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $21.9 million in Q4 2023 to a low of $5.8 million in Q2 2024.
  • Average Short term Debt over 4 years is $13.7 million, with a median of $13.1 million recorded in 2021.
  • Peak YoY movement for Short term Debt: surged 111.36% in 2023, then tumbled 59.91% in 2024.
  • A 4-year view of Short term Debt shows it stood at $17.8 million in 2021, then tumbled by 41.79% to $10.3 million in 2022, then soared by 111.36% to $21.9 million in 2023, then crashed by 73.29% to $5.8 million in 2024.
  • Per Business Quant, the three most recent readings for BDSX's Short term Debt are $5.8 million (Q2 2024), $19.2 million (Q1 2024), and $21.9 million (Q4 2023).